Skip to main content
. 2021 Feb 8;16(2):197–205. doi: 10.1007/s11523-021-00792-8

Fig. 1.

Fig. 1

Disease-specific survival according to a LDH and b S100B serum concentrations at baseline. BRAFi BRAF inhibitor therapy, HR hazard ratio, LDH lactate dehydrogenase, P p-value